TUMOUR NECROSIS FACTOR a EXPRESSION IN TUMOUR ISLETS CONFERS A SURVIVAL ADVANTAGE IN NON-SMALL CELL LUNG CANCER

被引:0
|
作者
Ohri, C. M. [1 ]
Shikotra, A. [1 ]
Green, R. H. [1 ]
Waller, D. A. [1 ]
Bradding, P. [1 ]
机构
[1] Glenfield Hosp, Inst Lung Hlth, Leicester, Leics, England
关键词
D O I
10.1136/thx.2009.127092p
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
引用
收藏
页码:A61 / A61
页数:1
相关论文
共 50 条
  • [21] Influence of tumour laterality on patient survival in non-small cell lung cancer after radiotherapy
    McWilliam, Alan
    Osorio, Eliana Vasquez
    Faivre-Finn, Corinne
    van Herk, Marcel
    RADIOTHERAPY AND ONCOLOGY, 2019, 137 : 71 - 76
  • [22] Tumour sphericity is an independent predictor for overall survival in non-small cell lung cancer.
    Davey, A.
    Van Herk, M.
    Faivre-Finn, C.
    McWilliam, A.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S1083 - S1083
  • [23] Tumour necrosis is an independent prognostic marker in non-small cell lung cancer: correlation with biological variables
    Swinson, DEB
    Jones, JL
    Richardson, D
    Cox, G
    Edwards, JG
    O'Byrne, KJ
    LUNG CANCER, 2002, 37 (03) : 235 - 240
  • [24] Spatial immunophenotyping of the tumour microenvironment in non-small cell lung cancer
    Backman, Max
    Strell, Carina
    Lindberg, Amanda
    Mattsson, Johanna S. M.
    Elfving, Hedvig
    Brunnstrom, Hans
    O'Reilly, Aine
    Bosic, Martina
    Gulyas, Miklos
    Isaksson, Johan
    Botling, Johan
    Karre, Klas
    Jirstrom, Karin
    Lamberg, Kristina
    Ponten, Fredrik
    Leandersson, Karin
    Mezheyeuski, Artur
    Micke, Patrick
    EUROPEAN JOURNAL OF CANCER, 2023, 185 : 40 - 52
  • [25] Tumour cell kinetics as prognostic factor in surgically-treated non-small cell lung cancer
    Gasinska, A
    Kolodziejski, L
    Biesaga, B
    LUNG CANCER, 1997, 18 (02) : 159 - 170
  • [26] Thymidine phosphorylase expression in tumour cells and tumour response to capecitabine plus docetaxel chemotherapy in non-small cell lung cancer
    Han, JY
    Hong, EK
    Lee, SY
    Yoon, SM
    Lee, DH
    Lee, JS
    JOURNAL OF CLINICAL PATHOLOGY, 2005, 58 (06) : 650 - 654
  • [27] Correlation of Gross Tumour Volume and metabolic Tumour Volume for non-small cell lung cancer patients
    Jameson, M. G.
    Oar, A. J.
    Field, M.
    Ho-Shon, I.
    Phan, P.
    Wang, D.
    Descallar, J.
    Pramana, A.
    Vinod, S.
    Koh, E.
    Holloway, L. C.
    RADIOTHERAPY AND ONCOLOGY, 2016, 118 : S51 - S52
  • [28] Macrophage and mast-cell invasion of tumor cell islets confers a marked survival advantage in non-small-cell lung cancer
    Welsh, TJ
    Green, RH
    Richardson, D
    Waller, DA
    O'Byrne, KJ
    Bradding, P
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (35) : 8959 - 8967
  • [29] Vascular endothelial growth factor directly stimulates tumour cell proliferation in non-small cell lung cancer
    Devery, Aoife M.
    Wadekar, Rekha
    Bokobza, Sivan M.
    Weber, Anika. M.
    Jiang, Yanyan
    Ryan, Anderson J.
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2015, 47 (03) : 849 - 856
  • [30] Circulating tumour cells in head and neck and non-small cell lung cancer
    O'Byrne, K. J.
    ANNALS OF ONCOLOGY, 2019, 30